Duration of immunotherapy in non-small cell lung cancer survivors: a lifelong commitment?
C Putzu, S Canova, P Paliogiannis, R Lobrano, L Sala… - Cancers, 2023 - mdpi.com
Simple Summary Lung cancer is one of the most common human cancers and the leading
cause of cancer-related mortality worldwide. The advent of immunotherapy for the treatment …
cause of cancer-related mortality worldwide. The advent of immunotherapy for the treatment …
Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy
Y Chen, L Gong, P Gu, Y Hua, Y Sun, S Ni, X Zhou… - BMC cancer, 2023 - Springer
Objectives Pan-immune-inflammation value (PIV) is defined by the neutrophil, platelet,
monocyte, and lymphocyte counts and is associated with immune-checkpoint inhibitor (ICI) …
monocyte, and lymphocyte counts and is associated with immune-checkpoint inhibitor (ICI) …
Identifying key transcription factors and immune infiltration in non-small-cell lung cancer using weighted correlation network and Cox regression analyses
J Zhang, Y Wang, B Yuan, H Qin, Y Wang, H Yu… - Frontiers in …, 2023 - frontiersin.org
Introduction Lung cancer is one of the most common cancers and a significant cause of
cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for about 85% of all …
cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for about 85% of all …
Advancing Nonsmall Cell Lung Cancer Diagnosis Accuracy via Dual Detection Fluorescent Nanoprobes
Y Wang, Z Chang, M Ouyang, K Wang, X Gao… - Analytical …, 2024 - ACS Publications
Among the primary threats to human health worldwide, nonsmall cell lung cancer (NSCLC)
remains a significant factor and is a leading cause of cancer-related deaths. Due to subtle …
remains a significant factor and is a leading cause of cancer-related deaths. Due to subtle …
RGMb impacts partial epithelial‐mesenchymal transition and BMP2‐Induced ID mRNA expression independent of PD‐L2 in nonsmall cell lung cancer cells
SR Dorset, TF Daugaard, TV Larsen… - Cell Biology …, 2023 - Wiley Online Library
Abstract PD‐1/PD‐ligand‐axis immunotherapy‐mediated activation of T‐cells for cancer cell
elimination is a promising treatment of nonsmall cell lung cancer (NSCLC). However, the …
elimination is a promising treatment of nonsmall cell lung cancer (NSCLC). However, the …
[HTML][HTML] Construction of immune cell infiltration score model to assess prognostic ability of tumor immune environment in lung adenocarcinoma
J Tian, C Fu, Q Peng, J Yang, X Fan… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Objectives: The immune cell infiltration (ICI) in the tumor microenvironment (TME) can
provide a reference for prognosis after immunotherapy. We aim to establish an ICI scoring …
provide a reference for prognosis after immunotherapy. We aim to establish an ICI scoring …
Lysosome-targeted ruthenium(II) complex encapsulated with pluronic® F-127 induces oncosis in A549 cells
N Pan, Y Zhang, M Huang, Z Liang, Y Gong… - JBIC Journal of …, 2024 - Springer
Transition metal complexes with characteristics of unique packaging in nanoparticles and
remarkable cancer cell cytotoxicity have emerged as potential alternatives to platinum …
remarkable cancer cell cytotoxicity have emerged as potential alternatives to platinum …
Hsa_circ_0096157 silencing suppresses autophagy and reduces cisplatin resistance in non-small cell lung cancer by weakening the Nrf2/ARE signaling pathway
H Lu, J Kong, S Cai, H Huang, J Luo, L Liu - Molecular Biology Reports, 2024 - Springer
Background Non-small cell lung cancer (NSCLC) is the leading cause of cancer morbidity
and mortality worldwide, and new diagnostic markers are urgently needed. We aimed to …
and mortality worldwide, and new diagnostic markers are urgently needed. We aimed to …
Mucosa‑associated lymphoid tissue lymphoma translocation protein 1 inhibitor, MI‑2, attenuates non‑small cell lung cancer cell proliferation, migration and invasion …
C Wu, W Ge, Y Wu - Oncology Letters, 2024 - spandidos-publications.com
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitors
are effective in attenuating the progression of several types of cancer. However, their role in …
are effective in attenuating the progression of several types of cancer. However, their role in …
PCDHGA10 as a Potential Biomarker of Lung Squamous Cell Carcinoma Based on Bioinformatics and Experimental Verification
S Song, R Lu, Y Chen, Y Feng - Molecular Biotechnology, 2024 - Springer
Procalcitonin gamma subfamily A, 10 (PCDHGA10) is a member of the procalcitonin gamma
gene cluster, which is associated with neuronal synapse development. However, there are …
gene cluster, which is associated with neuronal synapse development. However, there are …